NIH looking for off-label uses of drugs for rare diseases
In an effort to find new therapies for 6,000 rare diseases, National Institutes of Health researchers are screening drugs approved for other uses. They’re hoping to find off-label uses for the diseases afflicting some 25 million Americans.
“This is a critical step to explore the full potential of these drugs for new applications,” said Dr. Francis S. Collins, NIH director, in a statement. “The hope is that this process may identify some potential new treatments for rare and neglected diseases.”
The research is being coordinated by the NIH’s Chemical Genomics Center and uses information on 27,000 active drug ingredients included in the center’s publicly available pharmaceutical collection browser. It also includes 2,750 small molecule drugs with regulatory approval in the United States, Canada, Europe and Japan as well as those registered for human clinical trials. The center hopes to add more compounds.
For now, the focus is on collaboration with disease foundations, industry and academic investigators who can test the limited amounts of the compounds in the database. New clinical trials would be needed to test the drugs on the rare, and neglected, diseases. As would U.S. Food and Drug Administration approval.
The cost of drug development is so high that there are only therapies for less than 300 rare diseases now. But the hope is now that some of these other drugs have been vetted in large populations that there uses can be expanded. There are a few cases of new uses being found for drugs already.






Officials at the
The
Many metro areas around the country, including Baltimore-Washington, have made improvements in air quality in the last year, but half the nation still has unhealthy level of air pollution, according to the annual
A sprinkle of red pepper will burn more than your mouth, according to some new research. It can burn calories.
As we shed the bulky sweaters and heavy coats for warmer weather, the extra pounds we put on over the winter become more noticeable.
The bacterial infection MRSA is so potent that typical antibiotics don't kill it.
Seems like everyone these days suddenly has the long, luscious locks of Rapunzel. 
Many hospitals are making efforts to improve the quality of care but there isn’t consensus on how to measure the progress, says Dr. Peter J. Pronovost,
Exercise may be good for the body, but too much of it may be bad for the bones.
The U.S. Food and Drug Administration wants consumers to think about how many calories they're about to eat when they order at a restaurant.
Tonight City Hall will be lit up in blue for
Air cleaners can greatly reduce household air pollution and lower rates of asthma symptoms in children who live with smokers, according to a new


